Jazz Pharmaceuticals (JAZZ)
NASDAQ: JAZZ
· Real-Time Price · USD
117.19
0.23 (0.20%)
At close: May 01, 2025, 3:59 PM
115.39
-1.54%
After-hours: May 01, 2025, 05:47 PM EDT
Jazz Pharmaceuticals Revenue
Jazz Pharmaceuticals reported an annual revenue of $4.07B, reflecting a 6.12% growth. For the quarter ending December 31, 2024, Jazz Pharmaceuticals generated $1.09B in revenue.
Revenue (ttm)
$4.07B
Revenue Growth
6.12%
Price / Sales Ratio
1.87
Revenue / Employee
$1.45M
Employees
2,800
Market Cap
7.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 4.07B | +6.12% |
| Dec 31, 2023 | 3.83B | +4.78% |
| Dec 31, 2022 | 3.66B | +18.26% |
| Dec 31, 2021 | 3.09B | +30.91% |
| Dec 31, 2020 | 2.36B | n/a |